Stockscreener 앱 받기
0.8114
6.38%
-0.0553
시장 영업 전:
.82
0.0086
+1.06%
전일 마감가:
$0.8667
열려 있는:
$0.85
하루 거래량:
61,704
Relative Volume:
1.43
시가총액:
$44.37M
수익:
$117.93M
순이익/손실:
$5.00M
주가수익비율:
6.175
EPS:
0.1314
순현금흐름:
$-12.91M
1주 성능:
+0.17%
1개월 성능:
+6.75%
6개월 성능:
-41.63%
1년 성능:
-46.62%
1일 변동 폭
$0.77
$0.8667
1주일 범위
$0.77
$0.9389
52주 변동 폭
$0.68
$1.7698
Intercure Ltd Stock (INCR) Company Profile
Compare INCR vs TAK, ZTS, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INCR
Intercure Ltd
|
0.8114 | 47.39M | 117.93M | 5.00M | -12.91M | 0.1314 |
TAK
Takeda Pharmaceutical Co Adr
|
16.30 | 51.84B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
113.83 | 49.05B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.30 | 42.09B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.38 | 36.82B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
571.07 | 24.94B | 3.18B | 1.33B | 1.04B | 27.90 |
Intercure Ltd Stock (INCR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-05-18 | 업그레이드 | Canaccord Genuity | Speculative Buy → Buy |
Intercure Ltd 주식(INCR)의 최신 뉴스
Intercure (INCR) director discloses shares and stock options - Stock Titan
Intercure (INCR) director reports 15,000 share options at $3.10 strike - Stock Titan
Intercure (INCR) CEO details major share, warrant and option holdings - Stock Titan
David Salton Net Worth (2026) - GuruFocus
Amos Cohen Net Worth (2026) - GuruFocus
Gideon Hirschfeld Net Worth (2026) - GuruFocus
Intercure (INCR) CFO discloses option grants and share stake - Stock Titan
Intercure (INCR) director Gideon Hirschfeld reports existing stock option grants - Stock Titan
Intercure (INCR) director David Salton reports option positions in Form 3 - Stock Titan
Intercure (INCR) Stock: Portfolio Addition? (Selling Pressure) 2026-04-15Analyst Recommended Stocks - Cổng thông tin điện tử Tỉnh Sơn La
Investment Report: Whats the fair value of InterCure Ltd stockRisk Management & Consistent Growth Stock Picks - baoquankhu1.vn
Aug Levels: Is InterCure Ltd being accumulated by smart moneyExit Point & Weekly Breakout Stock Alerts - baoquankhu1.vn
Analyst Calls: How volatile is InterCure Ltd stock2026 Risk Factors & Short-Term High Return Ideas - baoquankhu1.vn
INCR PE Ratio & Valuation, Is INCR Overvalued - Intellectia AI
INCR Price Today: Intercure Ltd. Stock Price, Quote & Chart - MEXC Exchange
Stock Report: Is InterCure Ltd a potential multi bagger2026 Spike Watch & Safe Capital Preservation Plans - baoquankhu1.vn
Aug Update: Should I invest in InterCure Ltd before earnings2026 Top Decliners & Fast Moving Trade Plans - baoquankhu1.vn
INCR Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Highs Report: Why is InterCure Ltd stock going up2026 Performance Recap & Weekly Setup with High ROI Potential - baoquankhu1.vn
Stock Analysis: Is InterCure Ltd being accumulated by smart money2026 Macro Impact & Weekly Market Pulse Updates - baoquankhu1.vn
Aug Highlights: What are analysts price targets for InterCure LtdTreasury Yields & Accurate Intraday Trade Tips - baoquankhu1.vn
Intercure (INCR) Stock Analysis Report | Financials & Insights - Benzinga Japan
Market Fear: Is HCAT stock forming a triangle patternProduct Launch & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Will InterCure Ltd. stock split again soon2025 Analyst Calls & Daily Entry Point Trade Alerts - Naître et grandir
Aug Analyst Calls: Is InterCure Ltd a potential multi baggerWeekly Trade Report & Fast Gain Swing Trade Alerts - baoquankhu1.vn
INCR Earnings History & Surprises | EPS & Revenue Results | INTERCURE LTD (NASDAQ:INCR) - chartmill.com
INCR,UMBF Revenue Breakdown - Finviz
InterCure Faces Nasdaq Compliance Deadline After Bid-Price Breach - The Globe and Mail
InterCure receives Nasdaq notice for minimum bid price deficiency By Investing.com - Investing.com Canada
InterCure receives Nasdaq notice for minimum bid price deficiency - Investing.com South Africa
InterCure Receives Noncompliance Notice From Nasdaq - marketscreener.com
InterCure receives Nasdaq notification regarding minimum bid requirement - marketscreener.com
Nasdaq warns InterCure (Nasdaq: INCR) on sub-$1 share price and listing - Stock Titan
InterCure Ltd. Receives Nasdaq Compliance Notice Due to Bid Price Deficiency, Plans to Regain Compliance - Quiver Quantitative
InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement - GlobeNewswire
INCR Technical Analysis & Stock Price Forecast - Intellectia AI
Earnings Recap: Will RDACU outperform its industry peersJuly 2025 Fed Impact & Verified Chart Pattern Signals - baoquankhu1.vn
What’s the fair value of InterCure Ltd. stockChart Signals & Accurate Trade Setup Notifications - mfd.ru
InterCure Posts Higher 2025 Revenue and EBITDA, Resumes Nir Oz Output and Advances Expansion Plans - The Globe and Mail
Bearish Setup: Is InterCure Ltd being accumulated by smart money2025 Market Overview & Safe Capital Preservation Plans - baoquankhu1.vn
InterCure reports 11% revenue growth for 2025, enters German market By Investing.com - Investing.com Nigeria
InterCure reports 11% revenue growth for 2025, enters German market - Investing.com
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million - markets.businessinsider.com
Cannabis grower InterCure rebounds from Gaza war damage to NIS 265M sales - Stock Titan
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Million - Yahoo Finance
Risk Check: Why is InterCure Ltd stock going up2025 Top Decliners & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Why is InterCure Ltd. stock going upQuarterly Profit Report & Technical Buy Zone Confirmations - mfd.ru
What are InterCure Ltd.’s growth leversJuly 2025 Sentiment & Safe Entry Trade Signal Reports - mfd.ru
Hedge Fund Bets: Will InterCure Ltd. benefit from green energy policies2025 Volatility Report & Low Risk Investment Opportunities - baoquankhu1.vn
InterCure faces NIS 27 million exposure as key cannabis partner Bazelet enters restructuring - MSN
Head-To-Head Contrast: InterCure (NASDAQ:INCR) versus CompuMed (OTCMKTS:CMPD) - Defense World
Intercure Ltd (INCR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.58%
2.43%
자본화:
|
볼륨(24시간):